Jacobson publishes on severe COVID infection in pregnancy in Case Reports in Women’s Health
A new article by Maternal-Fetal Medicine fellow Jennifer Jacobson, MD outlines treatment of a severe COVID-19 infection in a pregnant patient, offering insight into care for other such patients in the future.
“Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report” is online now, and will appear in the January 2021 volume of Case Reports in Women’s Health:
“Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at 26 weeks of gestation with acute respiratory distress syndrome secondary to COVID-19 infection treated with dexamethasone, remdesivir, convalescent plasma and mechanical ventilation. Cesarean delivery was performed at 29 weeks due to worsening maternal status. This case offers insight into the assessment and successful use of treatment strategies, including dexamethasone, remdesivir, convalescent plasma, early prone positioning, conservative fluid management, permissive hypoxia and low tidal volume parameters with ventilator support for pregnancies affected by severe COVID-19 infection.”
UW Ob-Gyn MFM faculty Katie Antony, MD, Michael Beninati, MD, and Kara Hoppe, DO are co-authors on this case report. Read the whole article here. Amazing work, Dr. Jacobson!